The Technical AnalystExchange: STO Sector: Healthcare Industry: Medical Devices
Duearity AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.38% SEK0.410
America/New_York / 17 mai 2024 @ 11:13
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 10.79 mill |
| EPS: | -1.410 |
| P/E: | -0.290 |
| Earnings Date: | Mar 31, 2023 |
| SharesOutstanding: | 26.34 mill |
| Avg Daily Volume: | 0.126 mill |
| RATING 2024-05-17 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.290 | sector: PE 19.76 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -0.290 | industry: PE 54.10 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
SEK 0.266 - 0.554 ( +/- 35.16%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | SEK0.410 (2.38% ) |
| Volume | 0.0056 mill |
| Avg. Vol. | 0.126 mill |
| % of Avg. Vol | 4.42 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DEAR.ST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
DEAR.ST
Duearity AB (publ), a medical technology company, engages in the development of Tinearity, a tinnitus aid. The company's Tinearity contains a small sound element that generates white noise directly into the ear via the skull. It also develops Tinearity AI, an artificial intelligence-based solution that would help people suffering from or bothered by tinnitus to take command and master their symptoms. The company was incorporated in 2020 and is based in Malmö, Sweden.